2018 Global Pulmonary Hypertension Industry Report - History, Present and Future

December 2018 | 140 pages | ID: 2D0ADBB1289PEN
Prof Research

Abstracts

The global market size of Pulmonary Hypertension is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023. This report coverss following regions:

• North America
• South America
• Asia & Pacific
• Europe
• MEA (Middle East and Africa)

The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.

For competitor segment, the report includes global key players of Pulmonary Hypertension as well as some small players. The compnaies include:

Actelion, Bayer, GlaxoSmithKline, United Therapeutics, Aires Pharmaceuticals, Arena Pharmaceuticals, Bial, DEKA, Dong-A ST, Gilead, Merck, Northern Therapeutics, Novartis, Pfizer, PhaseBio, Radikal Th et al.

The information for each competitor includes:

• Company Profile
• Main Business Information
• SWOT Analysis
• Sales, Revenue, Price and Gross Margin
• Market Share

We also can offer customized report to fulfill special requirements of our clients.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Methodology
  3.2.1 Data Collection
  3.2.2 Data Analysis
  3.2.3 Data Validation
3.3 Research Sources
  3.3.1 Primary Sources
  3.3.2 Secondary Sources
  3.3.3 Assumptions

CHAPTER 4 MARKET LANDSCAPE

4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 Pulmonary Hypertension Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 TRADING ANALYSIS

8.1 Export of Pulmonary Hypertension by Region
8.2 Import of Pulmonary Hypertension by Region
8.3 Balance of Trade

CHAPTER 9 HISTORICAL AND CURRENT PULMONARY HYPERTENSION MARKET IN NORTH AMERICA (2013-2018)

9.1 Pulmonary Hypertension Supply
9.2 Pulmonary Hypertension Demand by End Use
9.3 Competition by Players/Suppliers
9.4 Type Segmentation and Price
9.5 Key Countries Analysis

CHAPTER 10 HISTORICAL AND CURRENT PULMONARY HYPERTENSION MARKET IN SOUTH AMERICA (2013-2018)

10.1 Pulmonary Hypertension Supply
10.2 Pulmonary Hypertension Demand by End Use
10.3 Competition by Players/Suppliers
10.4 Type Segmentation and Price
10.5 Key Countries Analysis

CHAPTER 11 HISTORICAL AND CURRENT PULMONARY HYPERTENSION MARKET IN ASIA & PACIFIC (2013-2018)

11.1 Pulmonary Hypertension Supply
11.2 Pulmonary Hypertension Demand by End Use
11.3 Competition by Players/Suppliers
11.4 Type Segmentation and Price
11.5 Key Countries Analysis

CHAPTER 12 HISTORICAL AND CURRENT PULMONARY HYPERTENSION MARKET IN EUROPE (2013-2018)

12.1 Pulmonary Hypertension Supply
12.2 Pulmonary Hypertension Demand by End Use
12.3 Competition by Players/Suppliers
12.4 Type Segmentation and Price
12.5 Key Countries Analysis

CHAPTER 13 HISTORICAL AND CURRENT PULMONARY HYPERTENSION MARKET IN MEA (2013-2018)

13.1 Pulmonary Hypertension Supply
13.2 Pulmonary Hypertension Demand by End Use
13.3 Competition by Players/Suppliers
13.4 Type Segmentation and Price
13.5 Key Countries Analysis

CHAPTER 14 SUMMARY FOR GLOBAL PULMONARY HYPERTENSION MARKET (2013-2018)

14.1 Pulmonary Hypertension Supply
14.2 Pulmonary Hypertension Demand by End Use
14.3 Competition by Players/Suppliers
14.4 Type Segmentation and Price

CHAPTER 15 GLOBAL PULMONARY HYPERTENSION MARKET FORECAST (2019-2023)

15.1 Pulmonary Hypertension Supply Forecast
15.2 Pulmonary Hypertension Demand Forecast
15.3 Competition by Players/Suppliers
15.4 Type Segmentation and Price Forecast

CHAPTER 16 COMPANY PROFILE(ACTELION, BAYER, GLAXOSMITHKLINE, UNITED THERAPEUTICS, AIRES PHARMACEUTICALS, ARENA PHARMACEUTICALS, BIAL, DEKA, DONG-A ST, GILEAD, MERCK, NORTHERN THERAPEUTICS, NOVARTIS, PFIZER, PHASEBIO, RADIKAL TH ET AL.)

16.1 Company A
  16.1.1 Company Profile
  16.1.2 Main Business and Pulmonary Hypertension Information
  16.1.3 SWOT Analysis of Company A
  16.1.4 Company A Pulmonary Hypertension Sales, Revenue, Price and Gross Margin (2013-2018)
16.2 Company B
  16.2.1 Company Profile
  16.2.2 Main Business and Pulmonary Hypertension Information
  16.2.3 SWOT Analysis of Company B
  16.2.4 Company B Pulmonary Hypertension Sales, Revenue, Price and Gross Margin (2013-2018)
16.3 Company C
  16.3.1 Company Profile
  16.3.2 Main Business and Pulmonary Hypertension Information
  16.3.3 SWOT Analysis of Company C
  16.3.4 Company C Pulmonary Hypertension Sales, Revenue, Price and Gross Margin (2013-2018)
16.4 Company D
  16.4.1 Company Profile
  16.4.2 Main Business and Pulmonary Hypertension Information
  16.4.3 SWOT Analysis of Company D
  16.4.4 Company D Pulmonary Hypertension Sales, Revenue, Price and Gross Margin (2013-2018)
16.5 Company E
  16.5.1 Company Profile
  16.5.2 Main Business and Pulmonary Hypertension Information
  16.5.3 SWOT Analysis of Company E
  16.5.4 Company E Pulmonary Hypertension Sales, Revenue, Price and Gross Margin (2013-2018)
16.6 Company F
  16.6.1 Company Profile
  16.6.2 Main Business and Pulmonary Hypertension Information
  16.6.3 SWOT Analysis of Company F
  16.6.4 Company F Pulmonary Hypertension Sales, Revenue, Price and Gross Margin (2013-2018)
16.7 Company G
  16.7.1 Company Profile
  16.7.2 Main Business and Pulmonary Hypertension Information
  16.7.3 SWOT Analysis of Company G
  16.7.4 Company G Pulmonary Hypertension Sales, Revenue, Price and Gross Margin (2013-2018)

Tables & Figures

TABLES AND FIGURES

Table Abbreviation and Acronyms List
Table Research Scope of Pulmonary Hypertension Report
Table Primary Sources of Pulmonary Hypertension Report
Table Secondary Sources of Pulmonary Hypertension Report
Table Major Assumptions of Pulmonary Hypertension Report
Figure Pulmonary Hypertension Picture
Table Pulmonary Hypertension Classification
Table Pulmonary Hypertension Applications List
Table Drivers of Pulmonary Hypertension Market
Table Restraints of Pulmonary Hypertension Market
Table Opportunities of Pulmonary Hypertension Market
Table Threats of Pulmonary Hypertension Market
Table Key Raw Material of Pulmonary Hypertension and Its Suppliers
Table Key Technologies of Pulmonary Hypertension
Table Cost Structure of Pulmonary Hypertension
Table Market Channel of Pulmonary Hypertension
Table Pulmonary Hypertension Application and Key End Users List
Table Latest News of Pulmonary Hypertension Industry
Table Recently Merger and Acquisition List of Pulmonary Hypertension Industry
Table Recently Planned/Future Project List of Pulmonary Hypertension Industry
Table Policy Dynamics Update of Pulmonary Hypertension Industry
Table 2013-2023 Export of Pulmonary Hypertension by Region
Table 2013-2023 Import of Pulmonary Hypertension by Region
Table 2013-2023 Balance of Trade of Pulmonary Hypertension
Figure 2013 2018 and 2023 Global Trade Map of Pulmonary Hypertension
Table 2013-2018 North America Supply of Pulmonary Hypertension
Figure 2013-2018 North America Pulmonary Hypertension Supply and GAGR
Table 2013-2018 North America Pulmonary Hypertension Downstream Demand List
Figure 2013-2018 North America Pulmonary Hypertension Downstream Demand and CAGR
Figure 2013 Major Players Market Share in North America
Figure 2018 Major Players Market Share in North America
Table 2013-2018 North America Pulmonary Hypertension Demand by Type
Figure 2013-2018 North America Pulmonary Hypertension Price
Table 2013-2018 Key Countries Supply of Pulmonary Hypertension in North America
Table 2013-2018 Key Countries Market Share of Supply in North America
Table 2013-2018 Key Countries Demand of Pulmonary Hypertension in North America
Table 2013-2018 Key Countries Market Share of Demand in North America
Table 2013-2018 South America Supply of Pulmonary Hypertension
Figure 2013-2018 South America Pulmonary Hypertension Supply and GAGR
Table 2013-2018 South America Pulmonary Hypertension Downstream Demand List
Figure 2013-2018 South America Pulmonary Hypertension Downstream Demand and CAGR
Figure 2013 Major Players Market Share in South America
Figure 2018 Major Players Market Share in South America
Table 2013-2018 South America Pulmonary Hypertension Demand by Type
Figure 2013-2018 South America Pulmonary Hypertension Price
Table 2013-2018 Key Countries Supply of Pulmonary Hypertension in South America
Table 2013-2018 Key Countries Market Share of Supply in South America
Table 2013-2018 Key Countries Demand of Pulmonary Hypertension in South America
Table 2013-2018 Key Countries Market Share of Demand in South America
Table 2013-2018 Asia & Pacific Supply of Pulmonary Hypertension
Figure 2013-2018 Asia & Pacific Pulmonary Hypertension Supply and GAGR
Table 2013-2018 Asia & Pacific Pulmonary Hypertension Downstream Demand List
Figure 2013-2018 Asia & Pacific Pulmonary Hypertension Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Asia & Pacific
Figure 2018 Major Players Market Share in Asia & Pacific
Table 2013-2018 Asia & Pacific Pulmonary Hypertension Demand by Type
Figure 2013-2018 Asia & Pacific Pulmonary Hypertension Price
Table 2013-2018 Key Countries Supply of Pulmonary Hypertension in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Supply in Asia & Pacific
Table 2013-2018 Key Countries Demand of Pulmonary Hypertension in Asia & Pacific
Table 2013-2018 Key Countries Market Share of Demand in Asia & Pacific
Table 2013-2018 Europe Supply of Pulmonary Hypertension
Figure 2013-2018 Europe Pulmonary Hypertension Supply and GAGR
Table 2013-2018 Europe Pulmonary Hypertension Downstream Demand List
Figure 2013-2018 Europe Pulmonary Hypertension Downstream Demand and CAGR
Figure 2013 Major Players Market Share in Europe
Figure 2018 Major Players Market Share in Europe
Table 2013-2018 Europe Pulmonary Hypertension Demand by Type
Figure 2013-2018 Europe Pulmonary Hypertension Price
Table 2013-2018 Key Countries Supply of Pulmonary Hypertension in Europe
Table 2013-2018 Key Countries Market Share of Supply in Europe
Table 2013-2018 Key Countries Demand of Pulmonary Hypertension in Europe
Table 2013-2018 Key Countries Market Share of Demand in Europe
Table 2013-2018 MEA Supply of Pulmonary Hypertension
Figure 2013-2018 MEA Pulmonary Hypertension Supply and GAGR
Table 2013-2018 MEA Pulmonary Hypertension Downstream Demand List
Figure 2013-2018 MEA Pulmonary Hypertension Downstream Demand and CAGR
Figure 2013 Major Players Market Share in MEA
Figure 2018 Major Players Market Share in MEA
Table 2013-2018 MEA Pulmonary Hypertension Demand by Type
Figure 2013-2018 MEA Pulmonary Hypertension Price
Table 2013-2018 Key Countries Supply of Pulmonary Hypertension in MEA
Table 2013-2018 Key Countries Market Share of Supply in MEA
Table 2013-2018 Key Countries Demand of Pulmonary Hypertension in MEA
Table 2013-2018 Key Countries Market Share of Demand in MEA
Table 2013-2018 Global Supply of Pulmonary Hypertension by Region
Figure 2013-2018 Global Supply and CAGR of Pulmonary Hypertension by Region
Table 2013-2018 Global Pulmonary Hypertension Downstream Demand List by Region
Figure 2013-2018 Global Pulmonary Hypertension Downstream Demand and CAGR by Region
Figure 2013 Global Major Players Market Share
Figure 2018 Global Major Players Market Share
Table 2013-2018 Global Pulmonary Hypertension Type-wise Demand by Region
Figure 2013-2018 Global Pulmonary Hypertension Price
Table Main Business and Pulmonary Hypertension Information of Company A
Table SWOT Analysis of Company A
Table 2013-2018 Company A Pulmonary Hypertension Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company A Pulmonary Hypertension Sales Revenue and Growth Rate
Figure 2013-2018 Company A Pulmonary Hypertension Market Share
Table Main Business and Pulmonary Hypertension Information of Company B
Table SWOT Analysis of Company B
Table 2013-2018 Company B Pulmonary Hypertension Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company B Pulmonary Hypertension Sales Revenue and Growth Rate
Figure 2013-2018 Company B Pulmonary Hypertension Market Share
Table Main Business and Pulmonary Hypertension Information of Company C
Table SWOT Analysis of Company C
Table 2013-2018 Company C Pulmonary Hypertension Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company C Pulmonary Hypertension Sales Revenue and Growth Rate
Figure 2013-2018 Company C Pulmonary Hypertension Market Share
Table Main Business and Pulmonary Hypertension Information of Company D
Table SWOT Analysis of Company D
Table 2013-2018 Company D Pulmonary Hypertension Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company D Pulmonary Hypertension Sales Revenue and Growth Rate
Figure 2013-2018 Company D Pulmonary Hypertension Market Share
Table Main Business and Pulmonary Hypertension Information of Company E
Table SWOT Analysis of Company E
Table 2013-2018 Company E Pulmonary Hypertension Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company E Pulmonary Hypertension Sales Revenue and Growth Rate
Figure 2013-2018 Company E Pulmonary Hypertension Market Share
Table Main Business and Pulmonary Hypertension Information of Company F
Table SWOT Analysis of Company F
Table 2013-2018 Company F Pulmonary Hypertension Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company F Pulmonary Hypertension Sales Revenue and Growth Rate
Figure 2013-2018 Company F Pulmonary Hypertension Market Share
Table Main Business and Pulmonary Hypertension Information of Company G
Table SWOT Analysis of Company G
Table 2013-2018 Company G Pulmonary Hypertension Sales, Revenue, Price, Cost and Gross Margin List
Figure 2013-2018 Company G Pulmonary Hypertension Sales Revenue and Growth Rate
Figure 2013-2018 Company G Pulmonary Hypertension Market Share